Candel Therapeutics (CADL) Change in Acquisitions & Divestments (2020)
Candel Therapeutics (CADL) reported Change in Acquisitions & Divestments of $20.6 million for Q4 2020, up 344116.67% sequentially from -$6000.0 in Q3 2020.
Candel Therapeutics (CADL) Change in Acquisitions & Divestments (2020) Analysis & Trends
Candel Therapeutics (CADL) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $20.6 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Candel Therapeutics | 504.70 Mn | 504.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 20.64 Mn |
| Dec 31, 2020 | 20.64 Mn |
| Sep 30, 2020 | -6,000.00 |
| Sep 30, 2020 | -6,000.00 |